K8·凯发(中国)天生赢家·一触即发
Promote a healthier life
for humankind through
advancements in science
Science-based
Benefit the patients with
high-quality medication as
we determined to innovate
Innovation-driven
Build a leading global
biopharmaceutical group
to serve more
Going Global
Fulfill social responsibilities
through accountable actions
Embrace Social
Responsibilities
Explore who we are
About us
Innovation is the core of our development strategy
Partnering
We are actively looking for synergistic partnerships
Walk into Hengrui
Est.
1970
Marketed Innovative Products in China
15
Partnered Innovative Product Launched
2
SH 600276
Est.
1970
Marketed Innovative Products in China
8
Partnered Innovative Product Launched
1
SH 600276
Pipeline
Our innovative pipeline covers the most of major therapeutic areas and continues to grow
Pipeline
Our innovative pipeline covers the most of major therapeutic areas and continues to grow
Investor
Enhance communication between our company and investors
Media
Hengrui Pharma Partners with Merck to Advance Innovative Cancer Therapies
Media
Jiangsu Hengrui Pharma and Elevar Therapeutics Announce Global Commercialization Licensing Agreement for PD-1 Inhibitor Camrelizumab in Combination with Rivoceranib for uHCC
Media
Hengrui Pharma Announces Positive Data of Two ADC Programs at the AACR Annual Meeting 2023
